WO2008064202A3 - Modified-release formulations of calcium receptor-active compounds - Google Patents

Modified-release formulations of calcium receptor-active compounds Download PDF

Info

Publication number
WO2008064202A3
WO2008064202A3 PCT/US2007/085191 US2007085191W WO2008064202A3 WO 2008064202 A3 WO2008064202 A3 WO 2008064202A3 US 2007085191 W US2007085191 W US 2007085191W WO 2008064202 A3 WO2008064202 A3 WO 2008064202A3
Authority
WO
WIPO (PCT)
Prior art keywords
modified
active compounds
calcium receptor
release formulations
formulations
Prior art date
Application number
PCT/US2007/085191
Other languages
French (fr)
Other versions
WO2008064202A2 (en
Inventor
Movva Snehalatha
Atul Vishvanath Patil
Narayanan Badri Vishwanathan
Indu Bhushan
Original Assignee
Reddy S Labortories Ltd Dr
Reddys Lab Inc Dr
Movva Snehalatha
Atul Vishvanath Patil
Narayanan Badri Vishwanathan
Indu Bhushan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy S Labortories Ltd Dr, Reddys Lab Inc Dr, Movva Snehalatha, Atul Vishvanath Patil, Narayanan Badri Vishwanathan, Indu Bhushan filed Critical Reddy S Labortories Ltd Dr
Publication of WO2008064202A2 publication Critical patent/WO2008064202A2/en
Publication of WO2008064202A3 publication Critical patent/WO2008064202A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Abstract

Modified-release pharmaceutical formulations comprising calcium receptor-active compounds, processes for preparing such formulations, and their methods of use. In an embodiment, the present invention relates to modified-release pharmaceutical formulations comprising cinacalcet or a pharmaceutically acceptable salt thereof.
PCT/US2007/085191 2006-11-20 2007-11-20 Modified-release formulations of calcium receptor-active compounds WO2008064202A2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
IN2147/CHE/2006 2006-11-20
IN2147CH2006 2006-11-20
IN2253CH2006 2006-12-05
IN2253/CHE/2006 2006-12-05
US88309407P 2007-01-02 2007-01-02
US60/883,094 2007-01-02
US88881807P 2007-02-08 2007-02-08
US60/888,818 2007-02-08

Publications (2)

Publication Number Publication Date
WO2008064202A2 WO2008064202A2 (en) 2008-05-29
WO2008064202A3 true WO2008064202A3 (en) 2008-10-30

Family

ID=39312936

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/085191 WO2008064202A2 (en) 2006-11-20 2007-11-20 Modified-release formulations of calcium receptor-active compounds

Country Status (1)

Country Link
WO (1) WO2008064202A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120009258A1 (en) 2008-09-25 2012-01-12 Ratiopharm Gmbh Compacted cinacalcet
WO2010086129A1 (en) 2009-01-27 2010-08-05 Rathiopharm Gmbh Inclusion complex comprising cinacalcet and cyclodextrin
EP2314286A1 (en) 2009-10-21 2011-04-27 Ratiopharm GmbH Melt granulated cinacalcet
WO2012071535A2 (en) * 2010-11-23 2012-05-31 Amgen Inc Pediatric formulation
CN102198108B (en) * 2011-05-18 2016-08-03 四川晖瑞医药科技有限公司 A kind of cinacalcet hydrochloride tablet or capsules preparation technique
WO2014029953A1 (en) * 2012-08-21 2014-02-27 Cipla Limited Hot melt extruded (hme) pharmaceutical composition of cinacalcet
PL2730279T3 (en) * 2012-11-09 2015-12-31 K H S Pharma Holding Gmbh Immediate release formulations of cinacalcet
CA2915432C (en) 2013-06-26 2019-03-05 Jubilant Life Sciences Limited Disintegrant free composition of cinacalcet
WO2015136329A1 (en) * 2014-03-14 2015-09-17 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical composition of cinacalcet
WO2015150944A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited Solid oral pharmaceutical compositions comprising cinacalcet or a salt thereof
CN104721164B (en) * 2015-03-25 2017-07-07 河北仁合益康药业有限公司 A kind of cinacalcet hydrochloride Film coated tablets composition
CN105106144A (en) * 2015-07-07 2015-12-02 沈阳药科大学 Cinacalcet hydrochloride solid dispersion tablet and preparation technology thereof
CN105213346B (en) * 2015-11-02 2019-03-26 北京泰德制药股份有限公司 A kind of pharmaceutical composition and preparation method thereof containing cinacalcet hydrochloride
EP3241549A1 (en) * 2016-05-02 2017-11-08 Sun Pharmaceutical Industries Limited Sprinkle composition of cinacalcet
CN109953979A (en) * 2017-12-25 2019-07-02 江苏恒瑞医药股份有限公司 Cinacalcet pharmaceutical composition and its medical usage

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005034928A1 (en) * 2003-09-12 2005-04-21 Amgen Inc. Rapid dissolution formulation of a calcium receptor-active compound
WO2008027522A2 (en) * 2006-09-01 2008-03-06 Teva Pharmaceutical Industries Ltd. Solid composites of a calicum receptor-active compound

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005034928A1 (en) * 2003-09-12 2005-04-21 Amgen Inc. Rapid dissolution formulation of a calcium receptor-active compound
WO2008027522A2 (en) * 2006-09-01 2008-03-06 Teva Pharmaceutical Industries Ltd. Solid composites of a calicum receptor-active compound

Also Published As

Publication number Publication date
WO2008064202A2 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
WO2008064202A3 (en) Modified-release formulations of calcium receptor-active compounds
WO2007117431A3 (en) Use of rasagiline for the treatment of restless legs syndrome
WO2006127932A3 (en) Purification of cinacalcet
WO2007002597A3 (en) Modified-release formulations of a bupropion salt
IL184771A (en) Compositions comprising n-halogenated amino acids and n,n- dihalogenated amino acids, their use for the manufacture of antibacterial medicaments, pharmaceutical compositions comprising them and a process for their preparation
WO2006127941A3 (en) Amorphous cinacalcet hydrochloride and preparation thereof
WO2008076348A8 (en) Crystalline solid rasagiline base
WO2007098264A3 (en) Use of rasagiline for the treatment of multiple system atrophy
IL180071A0 (en) Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
WO2006082523A3 (en) Pharmaceutical sustained release composition of metformin
WO2008027522A3 (en) Solid composites of a calicum receptor-active compound
IL184562A (en) Ibandronate polymorph a, process for its preparation and pharmaceutical compositions comprising the same
WO2007048027A3 (en) Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
ZA200703376B (en) Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals
ZA200801988B (en) 4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2006091836A8 (en) Formulations of ladostigil tartrate
WO2008003050A3 (en) Gallium nitrate formulations
WO2007029087A3 (en) Controlled release multiple unit formulations
WO2006134021A3 (en) Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
WO2008051564A3 (en) Crystalline forms of palonosetron hydrochloride
WO2009068708A8 (en) Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof
SI1742927T1 (en) Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
WO2007009686A3 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2009025792A3 (en) Crystalline forms cinacalcet fumarate and cinacalcet succinate and processes for preparation thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07871534

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07871534

Country of ref document: EP

Kind code of ref document: A2